{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:30:00Z","timestamp":1792740600331,"version":"4.5.0"},"reference-count":329,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T00:00:00Z","timestamp":1474502400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>\n                    Globally, group B\n                    <ns4:italic>Streptococcus<\/ns4:italic>\n                    (GBS) remains the leading cause of sepsis and meningitis in young infants, with its greatest burden in the first 90 days of life. Intrapartum antibiotic prophylaxis (IAP) for women at risk of transmitting GBS to their newborns has been effective in reducing, but not eliminating, the young infant GBS disease burden in many high income countries. However, identification of women at risk and administration of IAP is very difficult in many low and middle income country (LMIC) settings, and is not possible for home deliveries. Immunization of pregnant women with a GBS vaccine represents an alternate pathway to protecting newborns from GBS disease, through the transplacental antibody transfer to the fetus in utero. This approach to prevent GBS disease in young infants is currently under development, and is approaching late stage clinical evaluation.\n                  <\/ns4:p>\n                  <ns4:p>This manuscript includes a review of the natural history of the disease, global disease burden estimates, diagnosis and existing control options in different settings, the biological rationale for a vaccine including previous supportive studies, analysis of current candidates in development, possible correlates of protection and current status of immunogenicity assays. Future potential vaccine development pathways to licensure and use in LMICs, trial design and implementation options are discussed, with the objective to provide a basis for reflection, rather than recommendations.<\/ns4:p>","DOI":"10.12688\/f1000research.9363.1","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T05:15:04Z","timestamp":1474521304000},"page":"2355","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":78,"title":["Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries"],"prefix":"10.12688","volume":"5","author":[{"given":"Miwako","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3325-9073","authenticated-orcid":false,"given":"Johan","family":"Vekemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol J.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5104-085X","authenticated-orcid":false,"given":"Kirsty","family":"Le Doare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Schrag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2016,9,22]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"109-126","DOI":"10.1007\/978-1-62703-185-1_8","article-title":"Streptococci.","author":"L McGee","year":"2013"},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"e8-15","DOI":"10.1542\/peds.2011-3453","article-title":"Long-term outcomes of group B streptococcal meningitis.","volume":"130","author":"R Libster","year":"2012","journal-title":"Pediatrics."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"547-556","DOI":"10.1016\/S0140-6736(11)61651-6","article-title":"Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis.","volume":"379","author":"K Edmond","year":"2012","journal-title":"Lancet."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"430-440","DOI":"10.1016\/S0140-6736(14)61698-6","article-title":"Global, regional, and national causes of child mortality in 2000\u201313, with projections to inform post-2015 priorities: an updated systematic analysis.","volume":"385","author":"L Liu","year":"2015","journal-title":"Lancet."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"D20-26","DOI":"10.1016\/j.vaccine.2012.11.056","article-title":"Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.","volume":"31","author":"S Schrag","year":"2013","journal-title":"Vaccine."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"766-782","DOI":"10.3109\/14767058.2014.934804","article-title":"Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference.","volume":"28","author":"G Di Renzo","year":"2015","journal-title":"J Matern Fetal Neonatal Med."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"21-47","DOI":"10.1128\/CMR.00031-13","article-title":"Early-onset neonatal sepsis.","volume":"27","author":"K Simonsen","year":"2014","journal-title":"Clin Microbiol Rev."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"919-925","DOI":"10.1016\/S0022-3476(73)80524-4","article-title":"Transmission of group B streptococci among parturient women and their neonates.","volume":"83","author":"C Baker","year":"1973","journal-title":"J Pediatr."},{"key":"ref-9","first-page":"1-36","article-title":"Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.","volume":"59","author":"J Verani","year":"2010","journal-title":"MMWR Recomm Rep."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"237-239","DOI":"10.1111\/j.1471-0528.1984.tb04759.x","article-title":"Intrauterine infections with group B beta-haemolytic streptococci.","volume":"91","author":"D Desa","year":"1984","journal-title":"Br J Obstet Gynaecol."},{"key":"ref-11","first-page":"445-449","article-title":"Perinatal group B streptococcal infections across intact amniotic membranes.","volume":"33","author":"V Katz","year":"1988","journal-title":"J Reprod Med."},{"key":"ref-12","first-page":"476-479","article-title":"Neonatal infection: group B streptococcus.","author":"J Hanley","year":"2006","journal-title":"Clin Evid."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"1294-1303","DOI":"10.1111\/j.1469-0691.2011.03576.x","article-title":"Neonatal group B streptococcal disease: from pathogenesis to preventive strategies.","volume":"17","author":"P Melin","year":"2011","journal-title":"Clin Microbiol Infect."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"D7-12","DOI":"10.1016\/j.vaccine.2013.01.009","article-title":"An overview of global GBS epidemiology.","volume":"31","author":"K Le Doare","year":"2013","journal-title":"Vaccine."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"1909-1916","DOI":"10.1016\/S0140-6736(09)61339-8","article-title":"Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial.","volume":"374","author":"C Cutland","year":"2009","journal-title":"Lancet."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"34-38","DOI":"10.1016\/0002-9378(80)90382-8","article-title":"The natural history of group B streptococcal colonization in the pregnant woman and her offspring. I. Colonization studies.","volume":"137","author":"M Yow","year":"1980","journal-title":"Am J Obstet Gynecol."},{"key":"ref-17","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1542\/peds.103.6.e77","article-title":"Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review.","volume":"103","author":"W Benitz","year":"1999","journal-title":"Pediatrics."},{"key":"ref-18","first-page":"198-203","article-title":"Risk factors for early-onset group B streptococcal disease in neonates: a population-based case-control study.","volume":"169","author":"C Adair","year":"2003","journal-title":"CMAJ."},{"key":"ref-19","doi-asserted-by":"crossref","first-page":"544-549","DOI":"10.1542\/peds.68.4.544","article-title":"Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection.","volume":"68","author":"C Baker","year":"1981","journal-title":"Pediatrics."},{"key":"ref-20","doi-asserted-by":"crossref","first-page":"21-26","DOI":"10.1542\/peds.105.1.21","article-title":"Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study.","volume":"105","author":"A Schuchat","year":"2000","journal-title":"Pediatrics."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/bmj.325.7359.308","article-title":"Risk factors for early onset neonatal group B streptococcal sepsis: case-control study.","volume":"325","author":"S Oddie","year":"2002","journal-title":"BMJ."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"223-229","DOI":"10.3201\/eid1302.060680","article-title":"Invasive group B streptococcal infection in infants, Malawi.","volume":"13","author":"K Gray","year":"2007","journal-title":"Emerg Infect Dis."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"53-57","DOI":"10.1179\/146532806X90619","article-title":"Neonatal group B streptococcal infection at the University Hospital of the West Indies, Jamaica: a 10-year experience.","volume":"26","author":"H Trotman","year":"2006","journal-title":"Ann Trop Paediatr."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"e0123014","DOI":"10.1371\/journal.pone.0123014","article-title":"Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants.","volume":"10","author":"Z Dangor","year":"2015","journal-title":"PLoS One."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"15-23","DOI":"10.1179\/000349803125002814","article-title":"High burden of invasive Streptococcus agalactiae disease in South African infants.","volume":"23","author":"S Madhi","year":"2003","journal-title":"Ann Trop Paediatr."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"821-826","DOI":"10.1097\/INF.0b013e31825c4b5a","article-title":"Risk factors for neonatal sepsis and perinatal death among infants enrolled in the prevention of perinatal sepsis trial, Soweto, South Africa.","volume":"31","author":"S Schrag","year":"2012","journal-title":"Pediatr Infect Dis J."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"453-462","DOI":"10.1093\/infdis\/jiv064","article-title":"HIV-1 Is Associated With Lower Group B Streptococcus Capsular and Surface-Protein IgG Antibody Levels and Reduced Transplacental Antibody Transfer in Pregnant Women.","volume":"212","author":"Z Dangor","year":"2015","journal-title":"J Infect Dis."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"621-627","DOI":"10.1016\/j.vaccine.2014.12.025","article-title":"Anti-group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infection.","volume":"33","author":"K Le Doare","year":"2015","journal-title":"Vaccine."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"222-224","DOI":"10.1097\/INF.0000000000000974","article-title":"Incidence and Outcome of Group B Streptococcal Sepsis in Infants in Switzerland.","volume":"35","author":"E Giannoni","year":"2016","journal-title":"Pediatr Infect Dis J."},{"key":"ref-30","doi-asserted-by":"crossref","first-page":"124-125","DOI":"10.1016\/S0022-3476(78)80623-4","article-title":"Early onset group B streptococcal disease.","volume":"93","author":"C Baker","year":"1978","journal-title":"J Pediatr."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"910-916","DOI":"10.1016\/j.cmi.2015.05.039","article-title":"Group B streptococcus neonatal invasive infections, France 2007\u20132012.","volume":"21","author":"C Joubrel","year":"2015","journal-title":"Clin Microbiol Infect."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"15-20","DOI":"10.1056\/NEJM200001063420103","article-title":"Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.","volume":"342","author":"S Schrag","year":"2000","journal-title":"N Engl J Med."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"e97259","DOI":"10.1371\/journal.pone.0097259","article-title":"Prevalence of bloodstream pathogens is higher in neonatal encephalopathy cases vs. controls using a novel panel of real-time PCR assays.","volume":"9","author":"C Tann","year":"2014","journal-title":"PLoS One."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12887-015-0460-2","article-title":"Incidence and serotype distribution of invasive group B streptococcal disease in young infants: a multi-country observational study.","volume":"15","author":"L Rivera","year":"2015","journal-title":"BMC Pediatr."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"2056-2065","DOI":"10.1001\/jama.299.17.2056","article-title":"Epidemiology of invasive group B streptococcal disease in the United States, 1999\u20132005.","volume":"299","author":"C Phares","year":"2008","journal-title":"JAMA."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"375-392","DOI":"10.1016\/j.clp.2010.02.002","article-title":"Group B streptococcal disease in infants: progress in prevention and continued challenges.","volume":"37","author":"J Verani","year":"2010","journal-title":"Clin Perinatol."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"267-271","DOI":"10.1086\/376457","article-title":"Prematurity is the major risk factor for late-onset group B streptococcus disease.","volume":"188","author":"F Lin","year":"2003","journal-title":"J Infect Dis."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"1057-1064","DOI":"10.1097\/INF.0b013e318180b3b9","article-title":"Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis.","volume":"27","author":"H Jordan","year":"2008","journal-title":"Pediatr Infect Dis J."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"F41-47","DOI":"10.1136\/archdischild-2013-304362","article-title":"Group B streptococci in milk and late neonatal infections: an analysis of cases in the literature.","volume":"99","author":"A Filleron","year":"2014","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"347-350","DOI":"10.3346\/jkms.2006.21.2.347","article-title":"Outbreak of late-onset group B streptococcal infections in healthy newborn infants after discharge from a maternity hospital: a case report.","volume":"21","author":"H Kim","year":"2006","journal-title":"J Korean Med Sci."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"964-966","DOI":"10.1001\/archpedi.1980.02130220042013","article-title":"Nosocomial transmission of bacteriophage type 7\/11\/12 group B streptococci in a special care nursery.","volume":"134","author":"K Boyer","year":"1980","journal-title":"Am J Dis Child."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"283-288","DOI":"10.1016\/j.ajic.2009.08.011","article-title":"Outbreak of late-onset group B Streptococcus in a neonatal intensive care unit.","volume":"38","author":"J MacFarquhar","year":"2010","journal-title":"Am J Infect Control."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"672-677","DOI":"10.1093\/infdis\/162.3.672","article-title":"Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta.","volume":"162","author":"A Schuchat","year":"1990","journal-title":"J Infect Dis."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"674-680","DOI":"10.1136\/adc.2008.148874","article-title":"Group B streptococcal disease in infants: a case control study.","volume":"94","author":"P Heath","year":"2009","journal-title":"Arch Dis Child."},{"key":"ref-45","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piv067","article-title":"Risk Factors for Late-Onset Group B Streptococcal Disease Before and After Implementation of Universal Screening and Intrapartum Antibiotic Prophylaxis.","author":"J Pintye","year":"2015","journal-title":"J Pediatric Infect Dis Soc."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"e361-368","DOI":"10.1542\/peds.2012-1231","article-title":"Group B streptococcus late-onset disease: 2003\u20132010.","volume":"131","author":"A Berardi","year":"2013","journal-title":"Pediatrics."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"638-645","DOI":"10.3201\/eid2104.141562","article-title":"Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004\u201320081.","volume":"21","author":"C Cutland","year":"2015","journal-title":"Emerg Infect Dis."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"e631-638","DOI":"10.1542\/peds.2010-0183","article-title":"High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants.","volume":"126","author":"C Epalza","year":"2010","journal-title":"Pediatrics."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"1062-1076","DOI":"10.1097\/01.AOG.0000144128.03913.c2","article-title":"Perinatal infections due to group B streptococci.","volume":"104","author":"R Gibbs","year":"2004","journal-title":"Obstet Gynecol."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"F179-184","DOI":"10.1136\/fn.88.3.F179","article-title":"Long term outcome of neonatal meningitis.","volume":"88","author":"J Stevens","year":"2003","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"933-42","DOI":"10.1097\/INF.0000000000001233","article-title":"Disease Burden of Group B Streptococcus Among Infants in Sub-Saharan Africa: A Systematic Literature Review and Meta-Analysis.","volume":"35","author":"A Sinha","year":"2016","journal-title":"Pediatr Infect Dis J."},{"key":"ref-52","doi-asserted-by":"crossref","first-page":"1354-1360","DOI":"10.1016\/S0002-9378(96)70684-1","article-title":"Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group.","volume":"174","author":"J Regan","year":"1996","journal-title":"Am J Obstet Gynecol."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"427-433","DOI":"10.1067\/mob.2001.109936","article-title":"Association between colonization with group B streptococci during pregnancy and preterm delivery among Danish women.","volume":"184","author":"D Feikin","year":"2001","journal-title":"Am J Obstet Gynecol."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"958-967","DOI":"10.1080\/00016340903176800","article-title":"Association between colonization with Group B Streptococcus and preterm delivery: a systematic review.","volume":"88","author":"A Valkenburg-van den Berg","year":"2009","journal-title":"Acta Obstet Gynecol Scand."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"220-227","DOI":"10.1155\/S1064744900000314","article-title":"Intrauterine infection and spontaneous midgestation abortion: is the spectrum of microorganisms similar to that in preterm labor?","volume":"8","author":"H McDonald","year":"2000","journal-title":"Infect Dis Obstet Gynecol."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"114-123","DOI":"10.1093\/cid\/cir325","article-title":"Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women.","volume":"53","author":"M Deutscher","year":"2011","journal-title":"Clin Infect Dis."},{"key":"ref-57","first-page":"816-819","article-title":"Peripartum infection associated with vaginal group B streptococcal colonization.","volume":"84","author":"M Yancey","year":"1994","journal-title":"Obstet Gynecol."},{"key":"ref-58","doi-asserted-by":"publisher","first-page":"1410-1415","DOI":"10.1086\/314756","article-title":"Maternal peripartum complications associated with vaginal group B streptococci colonization.","volume":"179","author":"M Krohn","year":"1999","journal-title":"J Infect Dis."},{"key":"ref-59","doi-asserted-by":"publisher","first-page":"525-531","DOI":"10.3109\/00365548609021657","article-title":"Group B streptococci at delivery: high count in urine increases risk for neonatal colonization.","volume":"18","author":"K Persson","year":"1986","journal-title":"Scand J Infect Dis."},{"key":"ref-60","doi-asserted-by":"publisher","first-page":"601-606","DOI":"10.1016\/S0022-3476(05)81613-0","article-title":"Significance of a positive urine group B streptococcal latex agglutination test in neonates.","volume":"116","author":"P S\u00e1nchez","year":"1990","journal-title":"J Pediatr."},{"key":"ref-61","doi-asserted-by":"publisher","first-page":"1983-1986","DOI":"10.3109\/14767058.2012.671872","article-title":"Bacteruria with group-B streptococcus: is it a risk factor for adverse pregnancy outcomes?","volume":"25","author":"R Kessous","year":"2012","journal-title":"J Matern Fetal Neonatal Med."},{"key":"ref-62","doi-asserted-by":"publisher","first-page":"203-207","DOI":"10.1080\/10647440300025522","article-title":"Maternal group B streptococcal (GBS) genital tract colonization at term in women who have asymptomatic GBS bacteriuria.","volume":"11","author":"D McKenna","year":"2003","journal-title":"Infect Dis Obstet Gynecol."},{"key":"ref-63","doi-asserted-by":"publisher","first-page":"540-544","DOI":"10.1016\/S0029-7844(02)02097-5","article-title":"Intrapartum antibiotic prophylaxis 2: positive predictive value of antenatal group B streptococci cultures and antibiotic susceptibility of clinical isolates.","volume":"100","author":"R Edwards","year":"2002","journal-title":"Obstet Gynecol."},{"key":"ref-64","doi-asserted-by":"publisher","first-page":"679-684","DOI":"10.1016\/j.ijid.2008.10.007","article-title":"Invasive group B streptococcal infections in a tertiary care hospital between 1998 and 2007 in Japan.","volume":"13","author":"K Matsubara","year":"2009","journal-title":"Int J Infect Dis."},{"key":"ref-65","doi-asserted-by":"publisher","first-page":"1193-1199","DOI":"10.1007\/s10096-008-0565-8","article-title":"Invasive group B streptococcus (GBS) disease in Norway 1996\u20132006.","volume":"27","author":"H Bergseng","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"ref-66","doi-asserted-by":"publisher","first-page":"682-688","DOI":"10.1093\/cid\/cit337","article-title":"Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991\u20132010.","volume":"57","author":"T Lamagni","year":"2013","journal-title":"Clin Infect Dis."},{"key":"ref-67","doi-asserted-by":"publisher","first-page":"85-92","DOI":"10.1086\/599369","article-title":"Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990\u20132007.","volume":"49","author":"T Skoff","year":"2009","journal-title":"Clin Infect Dis."},{"key":"ref-68","article-title":"Oral abstract 64. Invasive bacterial infections in Thailand: finding from population-based surveillance in two provinces, 2010\u20132013.","author":"S Bhengsri","year":"2015"},{"key":"ref-69","doi-asserted-by":"publisher","first-page":"556-561","DOI":"10.1086\/322696","article-title":"Group B streptococcal disease in nonpregnant adults.","volume":"33","author":"M Farley","year":"2001","journal-title":"Clin Infect Dis."},{"key":"ref-70","doi-asserted-by":"publisher","first-page":"362-364","DOI":"10.1007\/PL00015020","article-title":"Invasive group B streptococcal disease in nonpregnant adults.","volume":"18","author":"O Perovic","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"ref-71","doi-asserted-by":"crossref","first-page":"192-194","DOI":"10.7883\/yoken.JJID.2009.192","article-title":"Group B Streptococcus infection: epidemiology, serotypes, and antimicrobial susceptibility of selected isolates in the population beyond infancy (excluding females with genital tract- and pregnancy-related isolates) at the University Malaya Medical Centre, Kuala Lumpur.","volume":"62","author":"R Karunakaran","year":"2009","journal-title":"Jpn J Infect Dis."},{"key":"ref-72","doi-asserted-by":"publisher","first-page":"168-173","DOI":"10.1086\/315699","article-title":"Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators.","volume":"182","author":"G Tyrrell","year":"2000","journal-title":"J Infect Dis."},{"key":"ref-73","doi-asserted-by":"publisher","first-page":"837-839","DOI":"10.1007\/s100960100612","article-title":"Invasive group B streptococcal disease in nonpregnant adults.","volume":"20","author":"M Bola\u00f1os","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"ref-74","doi-asserted-by":"publisher","first-page":"168-173","DOI":"10.1007\/s10096-003-1098-9","article-title":"Group B streptococcal disease in nonpregnant adults: incidence, clinical characteristics, and outcome.","volume":"23","author":"D Blancas","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"ref-75","doi-asserted-by":"publisher","first-page":"F350-354","DOI":"10.1136\/archdischild-2014-306193","article-title":"Early onset neonatal sepsis: diagnostic dilemmas and practical management.","volume":"100","author":"A Bedford Russell","year":"2015","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"ref-76","doi-asserted-by":"publisher","first-page":"D52-57","DOI":"10.1016\/j.vaccine.2013.02.029","article-title":"Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants.","volume":"31","author":"S Madhi","year":"2013","journal-title":"Vaccine."},{"key":"ref-77","article-title":"Stillbirths.","journal-title":"Maternal, newborn, child and adolescent health."},{"key":"ref-78","doi-asserted-by":"publisher","first-page":"574-86","DOI":"10.1016\/S0140-6736(15)00818-1","article-title":"Stillbirths: progress and unfinished business.","volume":"387","author":"J Fr\u00f8en","year":"2016","journal-title":"Lancet."},{"key":"ref-79","doi-asserted-by":"publisher","first-page":"784-788","DOI":"10.1097\/AOG.0000000000000717","article-title":"Rationalizing definitions and procedures for optimizing clinical care and public health in fetal death and stillbirth.","volume":"125","author":"K Joseph","year":"2015","journal-title":"Obstet Gynecol."},{"key":"ref-80","doi-asserted-by":"publisher","first-page":"141-153","DOI":"10.1111\/1471-0528.12995","article-title":"Causes of and factors associated with stillbirth in low- and middle-income countries: a systematic literature review.","volume":"121","author":"M Aminu","year":"2014","journal-title":"BJOG."},{"key":"ref-81","doi-asserted-by":"publisher","first-page":"587-603","DOI":"10.1016\/S0140-6736(15)00837-5","article-title":"Stillbirths: rates, risk factors, and acceleration towards 2030.","volume":"387","author":"J Lawn","year":"2016","journal-title":"Lancet."},{"key":"ref-82","doi-asserted-by":"publisher","first-page":"25-30","DOI":"10.1053\/sper.2002.29841","article-title":"The epidemiology of stillbirth.","volume":"26","author":"S Cnattingius","year":"2002","journal-title":"Semin Perinatol."},{"key":"ref-83","article-title":"Causes of child mortality.","year":"2015","journal-title":"Global Health Observatory (GHO) data."},{"key":"ref-84","article-title":"WHO-CHERG estimates for child causes for death, 2000\u20132012"},{"key":"ref-85","doi-asserted-by":"publisher","first-page":"S6-8","DOI":"10.1097\/INF.0000000000001099","article-title":"Aetiology of Neonatal Infection in South Asia (ANISA): An Initiative to Identify Appropriate Program Priorities to Save Newborns.","volume":"35","author":"S Saha","year":"2016","journal-title":"Pediatr Infect Dis J."},{"key":"ref-86","doi-asserted-by":"publisher","first-page":"S9-S15","DOI":"10.1097\/INF.0000000000001100","article-title":"Infection Surveillance Protocol for a Multicountry Population-based Study in South Asia to Determine the Incidence, Etiology and Risk Factors for Infections Among Young Infants of 0 to 59 Days Old.","volume":"35","author":"M Islam","year":"2016","journal-title":"Pediatr Infect Dis J."},{"key":"ref-87","doi-asserted-by":"publisher","first-page":"1057-1064","DOI":"10.1111\/tmi.12150","article-title":"Early-onset neonatal sepsis in Dhaka, Bangladesh: risk associated with maternal bacterial colonisation and chorioamnionitis.","volume":"18","author":"G Chan","year":"2013","journal-title":"Trop Med Int Health."},{"key":"ref-88","article-title":"Vaccine Preventable Infections Surveillance (VPIS) Project","year":"2014"},{"key":"ref-89","doi-asserted-by":"publisher","first-page":"437-439","DOI":"10.1016\/0029-7844(94)00412-7","article-title":"Enhanced antenatal detection of group B streptococcus colonization.","volume":"85","author":"E Philipson","year":"1995","journal-title":"Obstet Gynecol."},{"key":"ref-90","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/1471-2334-10-285","article-title":"Comparison of different sampling techniques and of different culture methods for detection of group B streptococcus carriage in pregnant women.","volume":"10","author":"N El Aila","year":"2010","journal-title":"BMC Infect Dis."},{"key":"ref-91","doi-asserted-by":"publisher","first-page":"499-503","DOI":"10.1097\/00006454-199806000-00013","article-title":"Maternal carriage of group B streptococci in developing countries.","volume":"17","author":"B Stoll","year":"1998","journal-title":"Pediatr Infect Dis J."},{"key":"ref-92","doi-asserted-by":"publisher","first-page":"267-274","DOI":"10.1080\/14767050410001668617","article-title":"The international infections in pregnancy study: group B streptococcal colonization in pregnant women.","volume":"15","author":"C Whitney","year":"2004","journal-title":"J Matern Fetal Neonatal Med."},{"key":"ref-93","doi-asserted-by":"publisher","first-page":"e98778","DOI":"10.1371\/journal.pone.0098778","article-title":"Serotype-specific acquisition and loss of group B streptococcus recto-vaginal colonization in late pregnancy.","volume":"9","author":"G Kwatra","year":"2014","journal-title":"PLoS One."},{"key":"ref-94","doi-asserted-by":"publisher","first-page":"e17861","DOI":"10.1371\/journal.pone.0017861","article-title":"Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads.","volume":"6","author":"M Madzivhandila","year":"2011","journal-title":"PLoS One."},{"key":"ref-95","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2334-12-34","article-title":"Group B streptococcal carriage, serotype distribution and antibiotic susceptibilities in pregnant women at the time of delivery in a refugee population on the Thai-Myanmar border.","volume":"12","author":"C Turner","year":"2012","journal-title":"BMC Infect Dis."},{"key":"ref-96","doi-asserted-by":"publisher","first-page":"1076-1084","DOI":"10.1016\/S1473-3099(16)30055-X","article-title":"Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis.","volume":"16","author":"G Kwatra","year":"2016","journal-title":"Lancet Infect Dis."},{"key":"ref-97","doi-asserted-by":"publisher","first-page":"1437-1445","DOI":"10.1111\/1471-0528.13527","article-title":"Maternal group B Streptococcus-related stillbirth: a systematic review.","volume":"122","author":"C Nan","year":"2015","journal-title":"BJOG."},{"key":"ref-98","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2016.67","article-title":"Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya.","volume":"1","author":"A Seale","year":"2016","journal-title":"Nat Microbiol."},{"key":"ref-99","doi-asserted-by":"publisher","first-page":"1071-1077","DOI":"10.1007\/s10096-010-0941-z","article-title":"Characterisation of invasive group B streptococci from adults in Denmark 1999 to 2004.","volume":"29","author":"L Lambertsen","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"ref-100","article-title":"WHO Recommendations for Prevention and Treatment of Maternal Peripartum Infections.","year":"2015"},{"key":"ref-101","doi-asserted-by":"publisher","first-page":"731-741","DOI":"10.1016\/S1473-3099(14)70804-7","article-title":"Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis.","volume":"14","author":"A Seale","year":"2014","journal-title":"Lancet Infect Dis."},{"key":"ref-102","article-title":"Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Childhood Illnesses.","year":"2013"},{"key":"ref-103","article-title":"Integrated Management of Childhood Illness chart booklet.","year":"2014"},{"key":"ref-104","doi-asserted-by":"publisher","first-page":"3-10","DOI":"10.1007\/0-387-32892-0_1","article-title":"Automated blood cultures.","author":"X Han","year":"2006"},{"key":"ref-105","doi-asserted-by":"publisher","first-page":"91-102","DOI":"10.1093\/cid\/cis395","article-title":"Variation in reported neonatal group B streptococcal disease incidence in developing countries.","volume":"55","author":"A Dagnew","year":"2012","journal-title":"Clin Infect Dis."},{"key":"ref-106","doi-asserted-by":"publisher","first-page":"18-22","DOI":"10.1038\/sj.jp.7211410","article-title":"A study of the role of multiple site blood cultures in the evaluation of neonatal sepsis.","volume":"26","author":"S Sarkar","year":"2006","journal-title":"J Perinatol."},{"key":"ref-107","doi-asserted-by":"publisher","first-page":"891-896","DOI":"10.1542\/peds.2006-0440","article-title":"How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital.","volume":"119","author":"T Connell","year":"2007","journal-title":"Pediatrics."},{"key":"ref-108","doi-asserted-by":"publisher","first-page":"F25-28","DOI":"10.1136\/fn.87.1.F25","article-title":"Blood cultures in newborns and children: optimising an everyday test.","volume":"87","author":"J Buttery","year":"2002","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"ref-109","doi-asserted-by":"publisher","first-page":"381-385","DOI":"10.1097\/00006454-199704000-00009","article-title":"Frequency of low level bacteremia in infants from birth to two months of age.","volume":"16","author":"J Kellogg","year":"1997","journal-title":"Pediatr Infect Dis J."},{"key":"ref-110","doi-asserted-by":"publisher","first-page":"275-278","DOI":"10.1016\/S0022-3476(96)70254-8","article-title":"Volume of blood required to detect common neonatal pathogens.","volume":"129","author":"R Schelonka","year":"1996","journal-title":"J Pediatr."},{"key":"ref-111","first-page":"411-456","article-title":"Group B Streptococcal Infections.","author":"M Edwards","year":"2016"},{"key":"ref-112","doi-asserted-by":"publisher","first-page":"e150-157","DOI":"10.1093\/cid\/ciu514","article-title":"Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance.","volume":"59","author":"I Okike","year":"2014","journal-title":"Clin Infect Dis."},{"key":"ref-113","doi-asserted-by":"publisher","first-page":"339-354","DOI":"10.1016\/j.clp.2010.02.003","article-title":"Diagnosis and management of clinical chorioamnionitis.","volume":"37","author":"A Tita","year":"2010","journal-title":"Clin Perinatol."},{"key":"ref-114","doi-asserted-by":"publisher","first-page":"649-669","DOI":"10.1016\/j.ogc.2014.08.007","article-title":"Current management and long-term outcomes following chorioamnionitis.","volume":"41","author":"C Johnson","year":"2014","journal-title":"Obstet Gynecol Clin North Am."},{"key":"ref-115","doi-asserted-by":"publisher","first-page":"509-520","DOI":"10.1016\/j.ccc.2013.03.006","article-title":"Obstetric infections.","volume":"29","author":"S Lapinsky","year":"2013","journal-title":"Crit Care Clin."},{"key":"ref-116","article-title":"Managing complications in pregnancy and childbirth: a guide for midwives and doctors.","year":"2000"},{"key":"ref-117","doi-asserted-by":"publisher","first-page":"69-87","DOI":"10.1016\/j.ogc.2012.11.007","article-title":"Maternal sepsis.","volume":"40","author":"J Morgan","year":"2013","journal-title":"Obstet Gynecol Clin North Am."},{"key":"ref-118","doi-asserted-by":"publisher","first-page":"236-246","DOI":"10.1016\/j.jmwh.2008.01.007","article-title":"Postpregnancy genital tract and wound infections.","volume":"53","author":"N Tharpe","year":"2008","journal-title":"J Midwifery Womens Health."},{"key":"ref-119","doi-asserted-by":"publisher","first-page":"182-189","DOI":"10.1016\/j.siny.2009.02.003","article-title":"Infection and stillbirth.","volume":"14","author":"E McClure","year":"2009","journal-title":"Semin Fetal Neonatal Med."},{"key":"ref-120","doi-asserted-by":"publisher","first-page":"918-925","DOI":"10.1056\/NEJMcpc079021","article-title":"Case records of the Massachusetts General Hospital. Case 27-2007. A 30-year-old pregnant woman with intrauterine fetal death.","volume":"357","author":"R Gibbs","year":"2007","journal-title":"N Engl J Med."},{"key":"ref-121","doi-asserted-by":"publisher","first-page":"1475-1482","DOI":"10.1128\/JCM.02365-10","article-title":"International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (Group B streptococci).","volume":"49","author":"B Afshar","year":"2011","journal-title":"J Clin Microbiol."},{"key":"ref-122","doi-asserted-by":"publisher","first-page":"441-458","DOI":"10.1084\/jem.59.4.441","article-title":"A Serological Differentiation of Specific Types of Bovine Hemolytic Streptococci (Group B).","volume":"59","author":"R Lancefield","year":"1934","journal-title":"J Exp Med."},{"key":"ref-123","doi-asserted-by":"crossref","first-page":"3268-3269","DOI":"10.1128\/JCM.30.12.3268-3269.1992","article-title":"Novel coagglutination method for serotyping group B streptococci.","volume":"30","author":"S H\u00e5kansson","year":"1992","journal-title":"J Clin Microbiol."},{"key":"ref-124","doi-asserted-by":"crossref","first-page":"2564-2567","DOI":"10.1128\/JCM.37.8.2564-2567.1999","article-title":"Inhibition enzyme-linked immunosorbent assay for serotyping of group B streptococcal isolates.","volume":"37","author":"G Arakere","year":"1999","journal-title":"J Clin Microbiol."},{"key":"ref-125","doi-asserted-by":"publisher","first-page":"408-409","DOI":"10.1128\/JCM.39.1.408-409.2001","article-title":"Detection of group B streptococcal colonization in pregnant women using direct latex agglutination testing of selective broth.","volume":"39","author":"C Park","year":"2001","journal-title":"J Clin Microbiol."},{"key":"ref-126","doi-asserted-by":"publisher","first-page":"503-507","DOI":"10.1128\/JCM.02417-12","article-title":"Capsular gene typing of Streptococcus agalactiae compared to serotyping by latex agglutination.","volume":"51","author":"K Yao","year":"2013","journal-title":"J Clin Microbiol."},{"key":"ref-127","doi-asserted-by":"publisher","first-page":"1985-1988","DOI":"10.1128\/JCM.00159-07","article-title":"Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci.","volume":"45","author":"C Poyart","year":"2007","journal-title":"J Clin Microbiol."},{"key":"ref-128","doi-asserted-by":"publisher","first-page":"212-214","DOI":"10.1016\/j.mimet.2009.11.010","article-title":"A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae.","volume":"80","author":"M Imperi","year":"2010","journal-title":"J Microbiol Methods."},{"key":"ref-129","doi-asserted-by":"publisher","first-page":"1388-90","DOI":"10.1128\/JCM.03142-15","article-title":"Capsular Typing Method for Streptococcus agalactiae Using Whole-Genome Sequence Data.","volume":"54","author":"A Sheppard","year":"2016","journal-title":"J Clin Microbiol."},{"key":"ref-130","doi-asserted-by":"publisher","first-page":"6431-6436","DOI":"10.1073\/pnas.1504725112","article-title":"Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes.","volume":"112","author":"A Flores","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-131","doi-asserted-by":"crossref","first-page":"919-925","DOI":"10.1128\/IAI.64.3.919-925.1996","article-title":"Population structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease.","volume":"64","author":"M Hauge","year":"1996","journal-title":"Infect Immun."},{"key":"ref-132","doi-asserted-by":"crossref","first-page":"1892-1898","DOI":"10.1128\/JCM.37.6.1892-1898.1999","article-title":"Genetic features of Streptococcus agalactiae strains causing severe neonatal infections, as revealed by pulsed-field gel electrophoresis and hylB gene analysis.","volume":"37","author":"K Rolland","year":"1999","journal-title":"J Clin Microbiol."},{"key":"ref-133","doi-asserted-by":"publisher","first-page":"2530-2536","DOI":"10.1128\/JCM.41.6.2530-2536.2003","article-title":"Multilocus sequence typing system for group B streptococcus.","volume":"41","author":"N Jones","year":"2003","journal-title":"J Clin Microbiol."},{"key":"ref-134","doi-asserted-by":"publisher","first-page":"3933-3943","DOI":"10.1128\/JCM.02411-14","article-title":"DNA microarray-based typing of Streptococcus agalactiae isolates.","volume":"52","author":"H Nitschke","year":"2014","journal-title":"J Clin Microbiol."},{"key":"ref-135","doi-asserted-by":"publisher","first-page":"2919-2926","DOI":"10.1128\/JCM.01128-15","article-title":"Emergence of Serotype IV Group B Streptococcus Adult Invasive Disease in Manitoba and Saskatchewan, Canada, Is Driven by Clonal Sequence Type 459 Strains.","volume":"53","author":"S Teatero","year":"2015","journal-title":"J Clin Microbiol."},{"key":"ref-136","article-title":"Guideline: Managing possible serious bacterial infection in young infants when referral is not feasible.","year":"2015"},{"key":"ref-137","doi-asserted-by":"publisher","first-page":"2915-2918","DOI":"10.1128\/AAC.00461-08","article-title":"Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.","volume":"52","author":"S Dahesh","year":"2008","journal-title":"Antimicrob Agents Chemother."},{"key":"ref-138","doi-asserted-by":"publisher","first-page":"2983-2985","DOI":"10.1128\/AAC.01243-10","article-title":"Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy.","volume":"55","author":"J Longtin","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"ref-139","doi-asserted-by":"publisher","first-page":"308-313","DOI":"10.1080\/00365540701678702","article-title":"Antimicrobial susceptibility of invasive group B streptococcal isolates from south-west Sweden 1988\u20132001.","volume":"40","author":"E Persson","year":"2008","journal-title":"Scand J Infect Dis."},{"key":"ref-140","doi-asserted-by":"publisher","first-page":"1-8","DOI":"10.1080\/10647440410001722269","article-title":"Antibiotic resistance patterns of group B streptococcal clinical isolates.","volume":"12","author":"J Simoes","year":"2004","journal-title":"Infect Dis Obstet Gynecol."},{"key":"ref-141","doi-asserted-by":"publisher","first-page":"2890-2897","DOI":"10.1128\/AAC.00185-08","article-title":"First molecular characterization of group B streptococci with reduced penicillin susceptibility.","volume":"52","author":"K Kimura","year":"2008","journal-title":"Antimicrob Agents Chemother."},{"key":"ref-142","doi-asserted-by":"publisher","first-page":"146-154","DOI":"10.1136\/archdischild-2012-302033","article-title":"Community-acquired neonatal and infant sepsis in developing countries: efficacy of WHO's currently recommended antibiotics--systematic review and meta-analysis.","volume":"98","author":"L Downie","year":"2013","journal-title":"Arch Dis Child."},{"key":"ref-143","doi-asserted-by":"publisher","first-page":"1665-1669","DOI":"10.1056\/NEJM198606263142603","article-title":"Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis.","volume":"314","author":"K Boyer","year":"1986","journal-title":"N Engl J Med."},{"key":"ref-144","first-page":"583-587","article-title":"Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients.","volume":"73","author":"N Tuppurainen","year":"1989","journal-title":"Obstet Gynecol."},{"key":"ref-145","doi-asserted-by":"publisher","first-page":"119-122","DOI":"10.1111\/j.1479-828X.1991.tb01797.x","article-title":"Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis.","volume":"31","author":"S Garland","year":"1991","journal-title":"Aust N Z J Obstet Gynaecol."},{"key":"ref-146","doi-asserted-by":"publisher","first-page":"1204-1210","DOI":"10.1067\/mob.2001.113875","article-title":"The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease.","volume":"184","author":"F Lin","year":"2001","journal-title":"Am J Obstet Gynecol."},{"key":"ref-147","doi-asserted-by":"publisher","first-page":"570-577","DOI":"10.1097\/AOG.0b013e318280d4f6","article-title":"Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease.","volume":"121","author":"T Fairlie","year":"2013","journal-title":"Obstet Gynecol."},{"key":"ref-148","article-title":"Penicillins, Cephalosporins, and other B-lactam Antibiotics.","author":"W Petri","year":"2006"},{"key":"ref-149","doi-asserted-by":"publisher","first-page":"705-721","DOI":"10.1016\/j.cell.2014.05.052","article-title":"Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences.","volume":"158","author":"L Cox","year":"2014","journal-title":"Cell."},{"key":"ref-150","doi-asserted-by":"publisher","first-page":"233-239","DOI":"10.1056\/NEJMoa020205","article-title":"A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.","volume":"347","author":"S Schrag","year":"2002","journal-title":"N Engl J Med."},{"key":"ref-151","article-title":"WHO Recommendations on Interventions to Improve Preterm Birth Outcomes.","year":"2015"},{"key":"ref-152","doi-asserted-by":"publisher","first-page":"692-698","DOI":"10.1016\/0029-7844(96)00004-X","article-title":"Prevention of early-onset group B streptococcal disease: another look at single-dose penicillin at birth.","volume":"87","author":"J Siegel","year":"1996","journal-title":"Obstet Gynecol."},{"key":"ref-153","doi-asserted-by":"publisher","first-page":"541-547","DOI":"10.1542\/peds.111.3.541","article-title":"Early-onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy.","volume":"111","author":"S Velaphi","year":"2003","journal-title":"Pediatrics."},{"key":"ref-154","doi-asserted-by":"publisher","first-page":"618-626","DOI":"10.1067\/mob.2002.122970","article-title":"Prevention of neonatal group B streptococcal disease: A combined intrapartum and neonatal protocol.","volume":"186","author":"G Wendel","year":"2002","journal-title":"Am J Obstet Gynecol."},{"key":"ref-155","doi-asserted-by":"publisher","first-page":"372-376","DOI":"10.1067\/mob.2000.107668","article-title":"Late third-trimester treatment of rectovaginal group B streptococci with benzathine penicillin G.","volume":"183","author":"M Bland","year":"2000","journal-title":"Am J Obstet Gynecol."},{"key":"ref-156","doi-asserted-by":"publisher","first-page":"633-635","DOI":"10.1111\/j.1471-0528.1983.tb09280.x","article-title":"The effect of intrapartum chemoprophylaxis on the vertical transmission of group B streptococci.","volume":"90","author":"C Easmon","year":"1983","journal-title":"Br J Obstet Gynaecol."},{"key":"ref-157","doi-asserted-by":"publisher","first-page":"240-243","DOI":"10.1016\/S0029-7844(97)00247-0","article-title":"Persistence of penicillin G benzathine in pregnant group B streptococcus carriers.","volume":"90","author":"J Weeks","year":"1997","journal-title":"Obstet Gynecol."},{"key":"ref-158","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3389\/fimmu.2014.00519","article-title":"Interaction of Streptococcus agalactiae and Cellular Innate Immunity in Colonization and Disease.","volume":"5","author":"S Landwehr-Kenzel","year":"2014","journal-title":"Front Immunol."},{"key":"ref-159","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1017\/S1462399408000811","article-title":"Recent advances in understanding the molecular basis of group B Streptococcus virulence.","volume":"10","author":"H Maisey","year":"2008","journal-title":"Expert Rev Mol Med."},{"key":"ref-160","doi-asserted-by":"publisher","first-page":"D13-19","DOI":"10.1016\/j.vaccine.2012.12.080","article-title":"A maternal vaccine against group B Streptococcus: past, present, and future.","volume":"31","author":"V Chen","year":"2013","journal-title":"Vaccine."},{"key":"ref-161","doi-asserted-by":"publisher","first-page":"1387-1399","DOI":"10.1586\/14787210.2015.1079126","article-title":"Group B streptococcal infections in the newborn infant and the potential value of maternal vaccination.","volume":"13","author":"A Berardi","year":"2015","journal-title":"Expert Rev Anti Infect Ther."},{"key":"ref-162","doi-asserted-by":"publisher","first-page":"653-666","DOI":"10.1038\/nri3737","article-title":"Siglec-mediated regulation of immune cell function in disease.","volume":"14","author":"M Macauley","year":"2014","journal-title":"Nat Rev Immunol."},{"key":"ref-163","doi-asserted-by":"publisher","first-page":"2929-2936","DOI":"10.1128\/JCM.00117-07","article-title":"Serotype IX, a Proposed New Streptococcus agalactiae Serotype.","volume":"45","author":"H Slotved","year":"2007","journal-title":"J Clin Microbiol."},{"key":"ref-164","first-page":"137-153","article-title":"Surface structures of group B Streptococcus important in human immunity.","author":"L Paoletti","year":"2000"},{"key":"ref-165","doi-asserted-by":"publisher","first-page":"915-924","DOI":"10.1086\/500324","article-title":"Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B streptococcus is independent of capsular serotype.","volume":"42","author":"N Jones","year":"2006","journal-title":"Clin Infect Dis."},{"key":"ref-166","doi-asserted-by":"publisher","first-page":"44-49","DOI":"10.1016\/j.mib.2011.12.002","article-title":"Group B Streptococcus surface proteins as major determinants for meningeal tropism.","volume":"15","author":"A Tazi","year":"2012","journal-title":"Curr Opin Microbiol."},{"key":"ref-167","doi-asserted-by":"publisher","first-page":"402-410","DOI":"10.1016\/S0966-842X(00)01823-0","article-title":"The role of cationic antimicrobial peptides in innate host defences.","volume":"8","author":"R Hancock","year":"2000","journal-title":"Trends Microbiol."},{"key":"ref-168","doi-asserted-by":"publisher","first-page":"2313-2322","DOI":"10.1084\/jem.20092594","article-title":"The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates.","volume":"207","author":"A Tazi","year":"2010","journal-title":"J Exp Med."},{"key":"ref-169","doi-asserted-by":"publisher","first-page":"753-756","DOI":"10.1056\/NEJM197604012941404","article-title":"Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.","volume":"294","author":"C Baker","year":"1976","journal-title":"N Engl J Med."},{"key":"ref-170","doi-asserted-by":"publisher","first-page":"105-110","DOI":"10.3109\/inf.1980.12.issue-2.06","article-title":"Quantitation of serum antibodies to surface antigens of group B streptococci types Ia, Ib, and III: low antibody levels in mothers of neonatally infected infants.","volume":"12","author":"K Christensen","year":"1980","journal-title":"Scand J Infect Dis."},{"key":"ref-171","doi-asserted-by":"publisher","first-page":"7-12","DOI":"10.1159\/000232980","article-title":"Mothers of infants with neonatal group B streptococcal septicemia are poor responders to bacterial carbohydrate antigens.","volume":"67","author":"K Christensen","year":"1982","journal-title":"Int Arch Allergy Appl Immunol."},{"key":"ref-172","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies.","volume":"2012","author":"P Palmeira","year":"2012","journal-title":"Clin Dev Immunol."},{"key":"ref-173","doi-asserted-by":"publisher","first-page":"248-253","DOI":"10.1097\/QCO.0b013e3283607a58","article-title":"Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants.","volume":"26","author":"B Lindsey","year":"2013","journal-title":"Curr Opin Infect Dis."},{"key":"ref-174","doi-asserted-by":"publisher","first-page":"213-221","DOI":"10.1097\/AOG.0000000000001190","article-title":"Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine: A Randomized Controlled Trial.","volume":"127","author":"G Donders","year":"2016","journal-title":"Obstet Gynecol."},{"key":"ref-175","doi-asserted-by":"publisher","first-page":"3468-3472","DOI":"10.1016\/S0264-410X(03)00353-0","article-title":"Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine.","volume":"21","author":"C Baker","year":"2003","journal-title":"Vaccine."},{"key":"ref-176","doi-asserted-by":"publisher","first-page":"538-539","DOI":"10.1097\/INF.0000000000000640","article-title":"Relevance of age at diagnosis to prevention of late-onset group B streptococcal disease by maternal immunization.","volume":"34","author":"M Edwards","year":"2015","journal-title":"Pediatr Infect Dis J."},{"key":"ref-177","doi-asserted-by":"crossref","first-page":"S13-16","DOI":"10.1097\/00006454-198805001-00004","article-title":"Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.","volume":"7","author":"G Fischer","year":"1988","journal-title":"Pediatr Infect Dis J."},{"key":"ref-178","article-title":"Women receiving group B Streptococcus serotype III tetanus toxoid (GBS-III-TT) vaccine have reduced vaginal and rectal acquisition of GBS type III.","author":"C Baker","year":"2009"},{"key":"ref-179","doi-asserted-by":"publisher","first-page":"568.e513-521","DOI":"10.1016\/j.cmi.2015.01.030","article-title":"Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women.","volume":"21","author":"G Kwatra","year":"2015","journal-title":"Clin Microbiol Infect."},{"key":"ref-180","first-page":"317-323","article-title":"Opsonization of group B Streptococcus type III: studies using clinical strains and maternal sera.","volume":"66","author":"M Hastings","year":"1985","journal-title":"Br J Exp Pathol."},{"key":"ref-181","doi-asserted-by":"publisher","first-page":"1-12","DOI":"10.1016\/S0022-3476(86)80761-2","article-title":"Immunologic basis for increased susceptibility of the neonate to infection.","volume":"108","author":"C Wilson","year":"1986","journal-title":"J Pediatr."},{"key":"ref-182","doi-asserted-by":"publisher","first-page":"1004-1008","DOI":"10.1093\/infdis\/140.6.1004","article-title":"Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.","volume":"140","author":"M Edwards","year":"1979","journal-title":"J Infect Dis."},{"key":"ref-183","doi-asserted-by":"crossref","first-page":"1278-1283","DOI":"10.4049\/jimmunol.128.3.1278","article-title":"Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.","volume":"128","author":"M Edwards","year":"1982","journal-title":"J Immunol."},{"key":"ref-184","doi-asserted-by":"publisher","first-page":"1127-1131","DOI":"10.1203\/00006450-198411000-00014","article-title":"Characteristics and functional capacities of human cord blood granulocytes and monocytes.","volume":"18","author":"L Mar\u00f3di","year":"1984","journal-title":"Pediatr Res."},{"key":"ref-185","doi-asserted-by":"publisher","first-page":"185-194","DOI":"10.1038\/nri2508","article-title":"B-cell responses to vaccination at the extremes of age.","volume":"9","author":"C Siegrist","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"ref-186","doi-asserted-by":"publisher","first-page":"333-342","DOI":"10.1016\/j.siny.2006.03.003","article-title":"SIRS and group-B streptococcal sepsis in newborns: pathogenesis and perspectives in adjunctive therapy.","volume":"11","author":"P Henneke","year":"2006","journal-title":"Semin Fetal Neonatal Med."},{"key":"ref-187","doi-asserted-by":"crossref","first-page":"741-744","DOI":"10.1128\/IAI.19.2.741-744.1978","article-title":"Adult mice as a model for early onset group B streptococcal disease.","volume":"19","author":"D Wennerstrom","year":"1978","journal-title":"Infect Immun."},{"key":"ref-188","doi-asserted-by":"publisher","first-page":"635-639","DOI":"10.1093\/infdis\/166.3.635","article-title":"Neonatal mouse model of group B streptococcal infection.","volume":"166","author":"A Rodewald","year":"1992","journal-title":"J Infect Dis."},{"key":"ref-189","doi-asserted-by":"publisher","first-page":"1150-1155","DOI":"10.1139\/m81-180","article-title":"Type III group B streptococcal infections in mice: bacteremia and meningitis following oral inoculation.","volume":"27","author":"J Lounsbery","year":"1981","journal-title":"Can J Microbiol."},{"key":"ref-190","doi-asserted-by":"publisher","first-page":"6324-6329","DOI":"10.4049\/jimmunol.172.10.6324","article-title":"Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease.","volume":"172","author":"G Mancuso","year":"2004","journal-title":"J Immunol."},{"key":"ref-191","doi-asserted-by":"crossref","first-page":"1023-1032","DOI":"10.1128\/IAI.27.3.1023-1032.1980","article-title":"Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes.","volume":"27","author":"P Ferrieri","year":"1980","journal-title":"Infect Immun."},{"key":"ref-192","doi-asserted-by":"crossref","first-page":"481-485","DOI":"10.1128\/IAI.19.2.481-485.1978","article-title":"Chicken embryo model for type III group B beta-hemolytic streptococcal septicemia.","volume":"19","author":"J Tieffenberg","year":"1978","journal-title":"Infect Immun."},{"key":"ref-193","doi-asserted-by":"publisher","first-page":"123-131","DOI":"10.1007\/PL00007594","article-title":"Lung function and bacterial proliferation in experimental neonatal pneumonia in ventilated rabbits exposed to monoclonal antibody to surfactant protein A.","volume":"176","author":"E Herting","year":"1998","journal-title":"Lung."},{"key":"ref-194","doi-asserted-by":"publisher","first-page":"899-904","DOI":"10.1203\/00006450-198106000-00003","article-title":"Studies on group B beta-hemolytic Streptococcus. II. Effects on pulmonary hemodynamics and vascular permeability in unanesthetized sheep.","volume":"15","author":"J Rojas","year":"1981","journal-title":"Pediatr Res."},{"key":"ref-195","doi-asserted-by":"publisher","first-page":"892-898","DOI":"10.1203\/00006450-198106000-00002","article-title":"Studies on group B beta-hemolytic Streptococcus. I. Isolation and partial characterization of an extracellular toxin.","volume":"15","author":"C Hellerqvist","year":"1981","journal-title":"Pediatr Res."},{"key":"ref-196","doi-asserted-by":"publisher","first-page":"107-110","DOI":"10.1203\/00006450-198302000-00005","article-title":"Effects of cyclooxygenase inhibition on the response to group B streptococcal toxin in sheep.","volume":"17","author":"J Rojas","year":"1983","journal-title":"Pediatr Res."},{"key":"ref-197","doi-asserted-by":"publisher","first-page":"659-669","DOI":"10.1161\/01.RES.61.5.659","article-title":"Group B streptococcal sepsis in the piglet: effects of fluid therapy on venous return, organ edema, and organ blood flow.","volume":"61","author":"M Bressack","year":"1987","journal-title":"Circ Res."},{"key":"ref-198","doi-asserted-by":"publisher","first-page":"686-690","DOI":"10.1016\/0002-9378(78)90865-7","article-title":"Experimental group B streptococcal infection in the rhesus monkey. I. Disease production in the neonate.","volume":"132","author":"J Larsen JW","year":"1978","journal-title":"Am J Obstet Gynecol."},{"key":"ref-199","doi-asserted-by":"publisher","first-page":"655-658","DOI":"10.1093\/infdis\/156.4.655","article-title":"Immunoprophylaxis of postnatally acquired group B streptococcal sepsis in neonatal rhesus monkeys.","volume":"156","author":"V Hemming","year":"1987","journal-title":"J Infect Dis."},{"key":"ref-200","doi-asserted-by":"publisher","first-page":"816-819","DOI":"10.1203\/00006450-198210000-00003","article-title":"Prevention of group B streptococcal colonization with topically applied lipoteichoic acid in a maternal-newborn mouse model.","volume":"16","author":"F Cox","year":"1982","journal-title":"Pediatr Res."},{"key":"ref-201","doi-asserted-by":"publisher","first-page":"1339-1348","DOI":"10.1038\/mi.2015.23","article-title":"Characterization of host immunity during persistent vaginal colonization by Group B Streptococcus.","volume":"8","author":"K Patras","year":"2015","journal-title":"Mucosal Immunol."},{"key":"ref-202","doi-asserted-by":"publisher","first-page":"1718-1731","DOI":"10.4049\/jimmunol.1202811","article-title":"Infection and cellular defense dynamics in a novel 17\u03b2-estradiol murine model of chronic human group B streptococcus genital tract colonization reveal a role for hemolysin in persistence and neutrophil accumulation.","volume":"192","author":"A Carey","year":"2014","journal-title":"J Immunol."},{"key":"ref-203","doi-asserted-by":"publisher","first-page":"265-273","DOI":"10.1093\/infdis\/jiu067","article-title":"Group B Streptococcus \u03b2-hemolysin\/cytolysin breaches maternal-fetal barriers to cause preterm birth and intrauterine fetal demise in vivo.","volume":"210","author":"T Randis","year":"2014","journal-title":"J Infect Dis."},{"key":"ref-204","doi-asserted-by":"crossref","first-page":"1315-1320","DOI":"10.1128\/IAI.13.5.1315-1320.1976","article-title":"Experimental group B streptococcal infections in mice: hematogenous virulence and mucosal colonization.","volume":"13","author":"D Furtado","year":"1976","journal-title":"Infect Immun."},{"key":"ref-205","doi-asserted-by":"publisher","first-page":"1154-1167","DOI":"10.1111\/cmi.12105","article-title":"Group B Streptococcus CovR regulation modulates host immune signalling pathways to promote vaginal colonization.","volume":"15","author":"K Patras","year":"2013","journal-title":"Cell Microbiol."},{"key":"ref-206","doi-asserted-by":"publisher","first-page":"982-991","DOI":"10.1093\/infdis\/jiu151","article-title":"Group B streptococcal serine-rich repeat proteins promote interaction with fibrinogen and vaginal colonization.","volume":"210","author":"N Wang","year":"2014","journal-title":"J Infect Dis."},{"key":"ref-207","doi-asserted-by":"publisher","first-page":"111-117","DOI":"10.1128\/AAC.49.1.111-117.2005","article-title":"Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme.","volume":"49","author":"Q Cheng","year":"2005","journal-title":"Antimicrob Agents Chemother."},{"key":"ref-208","doi-asserted-by":"publisher","first-page":"1118-1122","DOI":"10.1093\/infdis\/167.5.1118","article-title":"Prevention of group B streptococcal colonization and bacteremia in neonatal mice with topical vaginal inhibitors.","volume":"167","author":"F Cox","year":"1993","journal-title":"J Infect Dis."},{"key":"ref-209","doi-asserted-by":"publisher","first-page":"3342-3350","DOI":"10.1128\/IAI.73.6.3342-3350.2005","article-title":"The SrtA Sortase of Streptococcus agalactiae is required for cell wall anchoring of proteins containing the LPXTG motif, for adhesion to epithelial cells, and for colonization of the mouse intestine.","volume":"73","author":"L Lalioui","year":"2005","journal-title":"Infect Immun."},{"key":"ref-210","doi-asserted-by":"publisher","first-page":"1183-1186","DOI":"10.1203\/00006450-198511000-00014","article-title":"Rifampin and penicillin for the elimination of group B streptococci in nasally colonized infant rats.","volume":"19","author":"D Millard","year":"1985","journal-title":"Pediatr Res."},{"key":"ref-211","doi-asserted-by":"publisher","first-page":"803-808","DOI":"10.1016\/S0002-9378(99)70305-4","article-title":"A randomized trial of conjugated group B streptococcal type Ia vaccine in a rabbit model of ascending infection.","volume":"181","author":"J Davies","year":"1999","journal-title":"Am J Obstet Gynecol."},{"key":"ref-212","doi-asserted-by":"publisher","first-page":"60-70","DOI":"10.1155\/S1064744994000414","article-title":"Animal models of ascending genital-tract infection in pregnancy.","volume":"2","author":"R McDuffie","year":"1994","journal-title":"Infect Dis Obstet Gynecol."},{"key":"ref-213","doi-asserted-by":"publisher","first-page":"402-405","DOI":"10.1016\/S0002-9378(96)70153-9","article-title":"Ascending group B streptococcal genital infection in the rabbit model.","volume":"175","author":"J McDuffie RS","year":"1996","journal-title":"Am J Obstet Gynecol."},{"key":"ref-214","doi-asserted-by":"crossref","first-page":"599-603","DOI":"10.1128\/IAI.26.2.599-603.1979","article-title":"Experimental vaginal colonization and mother-infant transmission of group B streptococci in rats.","volume":"26","author":"R Ancona","year":"1979","journal-title":"Infect Immun."},{"key":"ref-215","doi-asserted-by":"publisher","first-page":"488-505","DOI":"10.15252\/emmm.201404883","article-title":"A streptococcal lipid toxin induces membrane permeabilization and pyroptosis leading to fetal injury.","volume":"7","author":"C Whidbey","year":"2015","journal-title":"EMBO Mol Med."},{"key":"ref-216","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/749432","article-title":"Pretreatment with pancaspase inhibitor (Z-VAD-FMK) delays but does not prevent intraperitoneal heat-killed group B Streptococcus-induced preterm delivery in a pregnant mouse model.","volume":"2009","author":"O Equils","year":"2009","journal-title":"Infect Dis Obstet Gynecol."},{"key":"ref-217","doi-asserted-by":"publisher","first-page":"320-330","DOI":"10.1093\/infdis\/164.2.320","article-title":"Pathophysiology and histopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: evidence for bacterial cellular invasion.","volume":"164","author":"C Rubens","year":"1991","journal-title":"J Infect Dis."},{"key":"ref-218","doi-asserted-by":"publisher","first-page":"e28972","DOI":"10.1371\/journal.pone.0028972","article-title":"Choriodecidual group B streptococcal inoculation induces fetal lung injury without intra-amniotic infection and preterm labor in Macaca nemestrina.","volume":"6","author":"K Adams Waldorf","year":"2011","journal-title":"PLoS One."},{"key":"ref-219","doi-asserted-by":"publisher","first-page":"e46863","DOI":"10.1371\/journal.pone.0046863","article-title":"Choriodecidual infection downregulates angiogenesis and morphogenesis pathways in fetal lungs from Macaca nemestrina.","volume":"7","author":"R McAdams","year":"2012","journal-title":"PLoS One."},{"key":"ref-220","doi-asserted-by":"publisher","first-page":"3909-3917","DOI":"10.1128\/IAI.00695-15","article-title":"Choriodecidual Group B Streptococcal Infection Induces miR-155-5p in the Fetal Lung in Macaca nemestrina.","volume":"83","author":"R McAdams","year":"2015","journal-title":"Infect Immun."},{"key":"ref-221","doi-asserted-by":"publisher","first-page":"81-88","DOI":"10.1093\/infdis\/140.1.81","article-title":"Mouse protection test for group B Streptococcus type III.","volume":"140","author":"R Baltimore","year":"1979","journal-title":"J Infect Dis."},{"key":"ref-222","doi-asserted-by":"publisher","first-page":"247-262","DOI":"10.1016\/0165-0378(95)00925-B","article-title":"Systemic and mucosal antibody responses to group B streptococci following immunization of the colonic-rectal mucosa.","volume":"28","author":"K Hordnes","year":"1995","journal-title":"J Reprod Immunol."},{"key":"ref-223","doi-asserted-by":"publisher","first-page":"850-861","DOI":"10.1016\/S0264-410X(00)00226-7","article-title":"Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.","volume":"19","author":"X Shen","year":"2000","journal-title":"Vaccine."},{"key":"ref-224","doi-asserted-by":"publisher","first-page":"5749-5755","DOI":"10.1128\/IAI.68.10.5749-5755.2000","article-title":"Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.","volume":"68","author":"X Shen","year":"2000","journal-title":"Infect Immun."},{"key":"ref-225","doi-asserted-by":"publisher","first-page":"3360-3368","DOI":"10.1016\/S0264-410X(00)00532-6","article-title":"Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate.","volume":"19","author":"X Shen","year":"2001","journal-title":"Vaccine."},{"key":"ref-226","doi-asserted-by":"publisher","first-page":"297-306","DOI":"10.1128\/IAI.69.1.297-306.2001","article-title":"Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization.","volume":"69","author":"X Shen","year":"2001","journal-title":"Infect Immun."},{"key":"ref-227","doi-asserted-by":"publisher","first-page":"1244-1251","DOI":"10.1016\/S0264-410X(97)00021-2","article-title":"Nasal immunization with group B streptococci can induce high levels of specific IgA antibodies in cervicovaginal secretions of mice.","volume":"15","author":"K Hordnes","year":"1997","journal-title":"Vaccine."},{"key":"ref-228","doi-asserted-by":"publisher","first-page":"114.e1-6","DOI":"10.1016\/j.ajog.2007.06.003","article-title":"Protective immunization in mice against group B streptococci using encapsulated C5a peptidase.","volume":"198","author":"D Santillan","year":"2008","journal-title":"Am J Obstet Gynecol."},{"key":"ref-229","doi-asserted-by":"publisher","first-page":"315-323","DOI":"10.1053\/siny.2002.0114","article-title":"Vaccines to prevent neonatal GBS infection.","volume":"7","author":"L Paoletti","year":"2002","journal-title":"Semin Neonatol."},{"key":"ref-230","doi-asserted-by":"publisher","first-page":"653-658","DOI":"10.1086\/315285","article-title":"Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate.","volume":"181","author":"L Paoletti","year":"2000","journal-title":"J Infect Dis."},{"key":"ref-231","doi-asserted-by":"publisher","first-page":"286-292","DOI":"10.1172\/JCI117319","article-title":"Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.","volume":"94","author":"L Madoff","year":"1994","journal-title":"J Clin Invest."},{"key":"ref-232","doi-asserted-by":"crossref","first-page":"3236-3243","DOI":"10.1128\/IAI.62.8.3236-3243.1994","article-title":"Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.","volume":"62","author":"L Paoletti","year":"1994","journal-title":"Infect Immun."},{"key":"ref-233","doi-asserted-by":"publisher","first-page":"1737-1746","DOI":"10.1021\/acschembio.5b00247","article-title":"Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.","volume":"10","author":"A Nilo","year":"2015","journal-title":"ACS Chem Biol."},{"key":"ref-234","doi-asserted-by":"publisher","first-page":"148-150","DOI":"10.1126\/science.1109869","article-title":"Identification of a universal Group B streptococcus vaccine by multiple genome screen.","volume":"309","author":"D Maione","year":"2005","journal-title":"Science."},{"key":"ref-235","doi-asserted-by":"publisher","first-page":"10278-10283","DOI":"10.1073\/pnas.1106590108","article-title":"Structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infections.","volume":"108","author":"A Nuccitelli","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-236","doi-asserted-by":"publisher","first-page":"102-127","DOI":"10.1128\/CMR.18.1.102-127.2005","article-title":"Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.","volume":"18","author":"G Lindahl","year":"2005","journal-title":"Clin Microbiol Rev."},{"key":"ref-237","doi-asserted-by":"crossref","first-page":"1421-1426","DOI":"10.1128\/IAI.61.4.1421-1426.1993","article-title":"Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal species.","volume":"61","author":"J Bohnsack","year":"1993","journal-title":"Infect Immun."},{"key":"ref-238","doi-asserted-by":"publisher","first-page":"847-855","DOI":"10.1086\/513981","article-title":"A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections.","volume":"175","author":"J Bohnsack","year":"1997","journal-title":"J Infect Dis."},{"key":"ref-239","doi-asserted-by":"publisher","DOI":"10.1201\/9781420048902.ch2","article-title":"Use of Animals for Vaccine Development","author":"A Onderdonk","year":"1999"},{"key":"ref-240","doi-asserted-by":"crossref","first-page":"677-679","DOI":"10.1128\/IAI.64.2.677-679.1996","article-title":"Immunogenicity of group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons.","volume":"64","author":"L Paoletti","year":"1996","journal-title":"Infect Immun."},{"key":"ref-241","doi-asserted-by":"publisher","first-page":"142-150","DOI":"10.1086\/314574","article-title":"Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib.","volume":"179","author":"C Baker","year":"1999","journal-title":"J Infect Dis."},{"key":"ref-242","doi-asserted-by":"publisher","first-page":"25-40","DOI":"10.1084\/jem.67.1.25","article-title":"Two Serological Types Of Group B Hemolytic Streptococci With Related, But Not Identical, Type-Specific Substances.","volume":"67","author":"R Lancefield","year":"1938","journal-title":"J Exp Med."},{"key":"ref-243","doi-asserted-by":"publisher","first-page":"1107-1110","DOI":"10.1172\/JCI109011","article-title":"Immunogenicity of polysaccharides from type III, group B Streptococcus.","volume":"61","author":"C Baker","year":"1978","journal-title":"J Clin Invest."},{"key":"ref-244","doi-asserted-by":"publisher","first-page":"375-378","DOI":"10.1136\/adc.88.5.375","article-title":"Group B streptococcal conjugate vaccines.","volume":"88","author":"C Baker","year":"2003","journal-title":"Arch Dis Child."},{"key":"ref-245","doi-asserted-by":"crossref","first-page":"458-467","DOI":"10.1093\/clinids\/7.4.458","article-title":"Group B streptococcal vaccines.","volume":"7","author":"C Baker","year":"1985","journal-title":"Rev Infect Dis."},{"key":"ref-246","doi-asserted-by":"publisher","first-page":"1180-1185","DOI":"10.1056\/NEJM198811033191802","article-title":"Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.","volume":"319","author":"C Baker","year":"1988","journal-title":"N Engl J Med."},{"key":"ref-247","doi-asserted-by":"publisher","first-page":"2308-2314","DOI":"10.1172\/JCI119042","article-title":"Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.","volume":"98","author":"D Kasper","year":"1996","journal-title":"J Clin Invest."},{"key":"ref-248","doi-asserted-by":"publisher","first-page":"1129-1138","DOI":"10.1086\/315839","article-title":"Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women.","volume":"182","author":"C Baker","year":"2000","journal-title":"J Infect Dis."},{"key":"ref-249","doi-asserted-by":"publisher","first-page":"1103-1112","DOI":"10.1086\/382193","article-title":"Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines.","volume":"189","author":"C Baker","year":"2004","journal-title":"J Infect Dis."},{"key":"ref-250","doi-asserted-by":"publisher","first-page":"76-90","DOI":"10.1177\/2051013615579869","article-title":"Group B Streptococcus vaccine: state of the art.","volume":"3","author":"A Nuccitelli","year":"2015","journal-title":"Ther Adv Vaccines."},{"key":"ref-251","doi-asserted-by":"publisher","first-page":"66-73","DOI":"10.1086\/375536","article-title":"Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III.","volume":"188","author":"C Baker","year":"2003","journal-title":"J Infect Dis."},{"key":"ref-252","doi-asserted-by":"publisher","first-page":"546-55","DOI":"10.1016\/S1473-3099(15)00484-3","article-title":"Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial.","volume":"16","author":"R Heyderman","year":"2016","journal-title":"Lancet Infect Dis."},{"key":"ref-253","doi-asserted-by":"publisher","first-page":"664-7","DOI":"10.1080\/21645515.2015.1086048","article-title":"Potential protective immunogenicity of tetanus toxoid, diphtheria toxoid and Cross Reacting Material 197 (CRM197) when used as carrier proteins in glycoconjugates.","volume":"12","author":"M Br\u00f6ker","year":"2016","journal-title":"Hum Vaccin Immunother."},{"key":"ref-254","first-page":"413-26","article-title":"Haeophilus influenzae type b (Hib) Vaccination Position Paper \u2013 July 2013.","volume":"88","year":"2013","journal-title":"Wkly Epidemiol Rec."},{"key":"ref-255","doi-asserted-by":"publisher","first-page":"2505-2523","DOI":"10.4161\/hv.26109","article-title":"Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.","volume":"9","author":"M Pichichero","year":"2013","journal-title":"Hum Vaccin Immunother."},{"key":"ref-256","article-title":"Information sheet. Observed rate of vaccine reactions. Pneumococcal vaccine","year":"2012"},{"key":"ref-257","doi-asserted-by":"publisher","first-page":"454-458","DOI":"10.1016\/S0264-410X(98)00218-7","article-title":"Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine.","volume":"17","author":"C Larsson","year":"1999","journal-title":"Vaccine."},{"key":"ref-258","doi-asserted-by":"publisher","first-page":"F403-408","DOI":"10.1136\/adc.2005.090472","article-title":"Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection.","volume":"91","author":"C Larsson","year":"2006","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"ref-259","article-title":"Minervax initiates phase I clinical trial with innovative group B streptococcal (GBS) vaccine to prevent life-threatening infections in newborns"},{"key":"ref-260","doi-asserted-by":"publisher","first-page":"108-115","DOI":"10.1086\/595564","article-title":"Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm.","volume":"199","author":"I Margarit","year":"2009","journal-title":"J Infect Dis."},{"key":"ref-261","doi-asserted-by":"publisher","first-page":"1651-1660","DOI":"10.1586\/14760584.2015.1085307","article-title":"Association between maternal Group B Streptococcus surface-protein antibody concentrations and invasive disease in their infants.","volume":"14","author":"Z Dangor","year":"2015","journal-title":"Expert Rev Vaccines."},{"key":"ref-262","doi-asserted-by":"publisher","first-page":"368-374","DOI":"10.1086\/338773","article-title":"Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum.","volume":"185","author":"C Lachenauer","year":"2002","journal-title":"J Infect Dis."},{"key":"ref-263","doi-asserted-by":"publisher","first-page":"1520-1524","DOI":"10.1111\/tmi.12400","article-title":"Accuracy of cerebrospinal leucocyte count, protein and culture for the diagnosis of acute bacterial meningitis: a comparative study using Bayesian latent class analysis.","volume":"19","author":"L Manning","year":"2014","journal-title":"Trop Med Int Health."},{"key":"ref-264","doi-asserted-by":"publisher","first-page":"353-356","DOI":"10.1086\/510627","article-title":"Group B Streptococcus bacteremia elicits beta C protein-specific IgMand IgG in humans.","volume":"195","author":"P Pannaraj","year":"2007","journal-title":"J Infect Dis."},{"key":"ref-265","doi-asserted-by":"publisher","first-page":"502-508","DOI":"10.1016\/j.vaccine.2007.11.034","article-title":"Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease.","volume":"26","author":"P Pannaraj","year":"2008","journal-title":"Vaccine."},{"key":"ref-266","doi-asserted-by":"publisher","first-page":"928-934","DOI":"10.1086\/422756","article-title":"Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen.","volume":"190","author":"F Lin","year":"2004","journal-title":"J Infect Dis."},{"key":"ref-267","doi-asserted-by":"publisher","first-page":"781-788","DOI":"10.1093\/infdis\/jit549","article-title":"Maternal antibody at delivery protects neonates from early onset group B streptococcal disease.","volume":"209","author":"C Baker","year":"2014","journal-title":"J Infect Dis."},{"key":"ref-268","doi-asserted-by":"publisher","first-page":"6793-6799","DOI":"10.1016\/j.vaccine.2015.10.019","article-title":"Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants.","volume":"33","author":"Z Dangor","year":"2015","journal-title":"Vaccine."},{"key":"ref-269","doi-asserted-by":"publisher","first-page":"1022-1028","DOI":"10.1086\/323350","article-title":"Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study.","volume":"184","author":"F Lin","year":"2001","journal-title":"J Infect Dis."},{"key":"ref-270","doi-asserted-by":"publisher","first-page":"855-858","DOI":"10.1086\/342411","article-title":"Seroepidemiologic studies of serotype VIII group B Streptococcus in Japan.","volume":"186","author":"K Matsubara","year":"2002","journal-title":"J Infect Dis."},{"key":"ref-271","doi-asserted-by":"publisher","first-page":"262-7","DOI":"10.1097\/QCO.0000000000000266","article-title":"Group B Streptococcus: developing a correlate of protection for a vaccine against neonatal infections.","volume":"29","author":"Z Dangor","year":"2016","journal-title":"Curr Opin Infect Dis."},{"key":"ref-272","doi-asserted-by":"publisher","first-page":"135-149","DOI":"10.1586\/14760584.2014.953939","article-title":"Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants.","volume":"14","author":"Z Dangor","year":"2015","journal-title":"Expert Rev Vaccines."},{"key":"ref-273","doi-asserted-by":"publisher","first-page":"401-409","DOI":"10.1086\/589862","article-title":"Vaccines: correlates of vaccine-induced immunity.","volume":"47","author":"S Plotkin","year":"2008","journal-title":"Clin Infect Dis."},{"key":"ref-274","article-title":"Correlates of vaccine-induced protection: methods and implications.","year":"2013"},{"key":"ref-275","doi-asserted-by":"crossref","first-page":"673-678","DOI":"10.4049\/jimmunol.118.2.673","article-title":"Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.","volume":"118","author":"R Baltimore","year":"1977","journal-title":"J Immunol."},{"key":"ref-276","doi-asserted-by":"publisher","first-page":"568.e13-568.e21","DOI":"10.1016\/j.cmi.2015.01.030","article-title":"Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women.","volume":"21","author":"G Kwatra","year":"2015","journal-title":"Clin Microbiol Infect."},{"key":"ref-277","doi-asserted-by":"publisher","first-page":"319-326","DOI":"10.1128\/CVI.00803-14","article-title":"Antibody-mediated complement C3b\/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.","volume":"22","author":"J Herbert","year":"2015","journal-title":"Clin Vaccine Immunol."},{"key":"ref-278","doi-asserted-by":"publisher","first-page":"1724-1738","DOI":"10.1128\/IAI.70.4.1724-1738.2002","article-title":"Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14.","volume":"70","author":"H Guttormsen","year":"2002","journal-title":"Infect Immun."},{"key":"ref-279","doi-asserted-by":"crossref","first-page":"4303-4305","DOI":"10.1128\/IAI.67.8.4303-4305.1999","article-title":"Measurement of human antibodies to type III group B Streptococcus.","volume":"67","author":"D Kasper","year":"1999","journal-title":"Infect Immun."},{"key":"ref-280","doi-asserted-by":"publisher","first-page":"648-655","DOI":"10.1093\/infdis\/148.4.648","article-title":"Estimation of the protective level of human IgG antibody to the type-specific polysaccharide of group B Streptococcus type Ia.","volume":"148","author":"M Klegerman","year":"1983","journal-title":"J Infect Dis."},{"key":"ref-281","doi-asserted-by":"publisher","first-page":"628-630","DOI":"10.1016\/S0022-3476(84)80436-9","article-title":"Quantitation of IgG antibody to the type-specific polysaccharide of group B streptococcus type 1b in pregnant women and infected infants.","volume":"105","author":"S Gotoff","year":"1984","journal-title":"J Pediatr."},{"key":"ref-282","doi-asserted-by":"publisher","first-page":"1073-1080","DOI":"10.1093\/infdis\/151.6.1073","article-title":"Seroepidemiological studies of group B Streptococcus type II.","volume":"151","author":"B Gray","year":"1985","journal-title":"J Infect Dis."},{"key":"ref-283","doi-asserted-by":"publisher","first-page":"511-519","DOI":"10.1093\/infdis\/153.3.511","article-title":"Human IgG antibody to group b Streptococcus type III: comparison of protective levels in a murine model with levels in infected human neonates.","volume":"153","author":"S Gotoff","year":"1986","journal-title":"J Infect Dis."},{"key":"ref-284","doi-asserted-by":"publisher","first-page":"883-887","DOI":"10.1093\/infdis\/162.4.883","article-title":"Prevalence of anti-group B streptococcal type III capsular IgG antibodies in the United Kingdom and an analysis of their specific IgG subclasses.","volume":"162","author":"R Feldman","year":"1990","journal-title":"J Infect Dis."},{"key":"ref-285","first-page":"198-208","article-title":"Tetanus vaccine","volume":"81","year":"2006","journal-title":"Wkly Epidemiol Rec."},{"key":"ref-286","first-page":"433-460","article-title":"Pertussis vaccines: WHO position paper - August 2015.","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec."},{"key":"ref-287","first-page":"461-476","article-title":"Vaccines against influenza WHO position paper \u2013 November 2012.","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec."},{"key":"ref-288","doi-asserted-by":"publisher","first-page":"966-972","DOI":"10.1016\/j.vaccine.2014.12.068","article-title":"Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy.","volume":"33","author":"J Roberts","year":"2015","journal-title":"Vaccine."},{"key":"ref-289","first-page":"301-312","article-title":"Global Advisory Committee on Vaccine Safety, 12\u201313 June 2013.","volume":"88","year":"2013","journal-title":"Wkly Epidemiol Rec."},{"key":"ref-290","article-title":"Safety of Immunization during Pregnancy. A review of Evidence","year":"2014"},{"key":"ref-291","doi-asserted-by":"publisher","first-page":"478.e1-6","DOI":"10.1016\/j.ajog.2013.02.027","article-title":"Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the Vaccine Adverse Event Reporting System.","volume":"208","author":"Y Zheteyeva","year":"2013","journal-title":"Am J Obstet Gynecol."},{"key":"ref-292","doi-asserted-by":"publisher","first-page":"S489-492","DOI":"10.1093\/cid\/civ625","article-title":"The Safety of PsA-TT in Pregnancy: An Assessment Performed Within the Navrongo Health and Demographic Surveillance Site in Ghana.","volume":"61","author":"G Wak","year":"2015","journal-title":"Clin Infect Dis."},{"key":"ref-293","doi-asserted-by":"publisher","first-page":"893-900","DOI":"10.1128\/CVI.00066-11","article-title":"Evaluation of a novel chimeric B cell epitope-based vaccine against mastitis induced by either Streptococcus agalactiae or Staphylococcus aureus in mice.","volume":"18","author":"H Xu","year":"2011","journal-title":"Clin Vaccine Immunol."},{"key":"ref-294","doi-asserted-by":"publisher","first-page":"146-151","DOI":"10.1016\/j.smim.2013.05.005","article-title":"Carbohydrates and T cells: a sweet twosome.","volume":"25","author":"F Avci","year":"2013","journal-title":"Semin Immunol."},{"key":"ref-295","doi-asserted-by":"publisher","first-page":"1786-91","DOI":"10.1016\/j.vaccine.2016.02.044","article-title":"A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women.","volume":"34","author":"G Leroux-Roels","year":"2016","journal-title":"Vaccine."},{"key":"ref-296","doi-asserted-by":"publisher","first-page":"923-34","DOI":"10.1016\/S1473-3099(16)00152-3","article-title":"Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b\/2 trial.","volume":"16","author":"S Madhi","year":"2016","journal-title":"Lancet Infect Dis."},{"key":"ref-297","doi-asserted-by":"publisher","first-page":"1442-1448","DOI":"10.1001\/jama.1993.03510120064032","article-title":"Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis.","volume":"270","author":"J Mohle-Boetani","year":"1993","journal-title":"JAMA."},{"key":"ref-298","doi-asserted-by":"publisher","article-title":"Vaccines for the 21st Century: A Tool for Decisionmaking","year":"2000","DOI":"10.17226\/5501"},{"key":"ref-299","doi-asserted-by":"publisher","first-page":"3187-3195","DOI":"10.1016\/j.vaccine.2004.12.021","article-title":"The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis.","volume":"23","author":"A Sinha","year":"2005","journal-title":"Vaccine."},{"key":"ref-300","doi-asserted-by":"publisher","first-page":"1-226","DOI":"10.3310\/hta11290","article-title":"Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses.","volume":"11","author":"T Colbourn","year":"2007","journal-title":"Health Technol Assess."},{"key":"ref-301","doi-asserted-by":"publisher","first-page":"1954-1963","DOI":"10.1016\/j.vaccine.2014.01.062","article-title":"Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa.","volume":"32","author":"S Kim","year":"2014","journal-title":"Vaccine."},{"key":"ref-302","doi-asserted-by":"publisher","first-page":"4778-4785","DOI":"10.1016\/j.vaccine.2014.06.003","article-title":"Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?","volume":"32","author":"G Oster","year":"2014","journal-title":"Vaccine."},{"key":"ref-303","doi-asserted-by":"publisher","first-page":"780-786","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.","volume":"10","author":"N Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol."},{"key":"ref-304","first-page":"129-144","article-title":"Pneumococcal vaccines WHO position paper--2012.","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec."},{"key":"ref-305","article-title":"Guidance for industry: Clinical Data Needed to Support the Licensure of Seasonal Inactivated Influenza Vaccines.","year":"2007","journal-title":"Vaccines Guidances."},{"key":"ref-306","article-title":"Guideline on influenza vaccines: non-clinical and clinical module","year":"2014"},{"key":"ref-307","doi-asserted-by":"publisher","first-page":"1304-1312","DOI":"10.1086\/522428","article-title":"A framework for assessing immunological correlates of protection in vaccine trials.","volume":"196","author":"L Qin","year":"2007","journal-title":"J Infect Dis."},{"key":"ref-308","doi-asserted-by":"publisher","first-page":"222-228","DOI":"10.1046\/j.1469-0691.2002.00417.x","article-title":"Evaluation of the VITAL (bioM\u00e9rieux) automated blood culture system using blind subculture.","volume":"8","author":"M Gim\u00e9nez","year":"2002","journal-title":"Clin Microbiol Infect."},{"key":"ref-309","doi-asserted-by":"publisher","first-page":"334-341","DOI":"10.1046\/j.1365-3016.2002.00437.x","article-title":"Epidemiology of neonatal group B streptococcal disease in The Netherlands 1997\u201398.","volume":"16","author":"M Trijbels-Smeulders","year":"2002","journal-title":"Paediatr Perinat Epidemiol."},{"key":"ref-310","doi-asserted-by":"publisher","first-page":"1953-1954","DOI":"10.1016\/S0140-6736(03)13553-2","article-title":"Estimated early-onset group B streptococcal neonatal disease.","volume":"361","author":"S Luck","year":"2003","journal-title":"Lancet."},{"key":"ref-311","doi-asserted-by":"publisher","first-page":"F85-89","DOI":"10.1136\/adc.2007.119958","article-title":"Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection.","volume":"93","author":"X Carbonell-Estrany","year":"2008","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"ref-312","doi-asserted-by":"publisher","first-page":"2413-2420","DOI":"10.1007\/s10096-015-2496-5","article-title":"Real-time polymerase chain reaction and culture in the diagnosis of invasive group B streptococcal disease in infants: a retrospective study.","volume":"34","author":"M Meehan","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"ref-313","doi-asserted-by":"publisher","first-page":"6453-6465","DOI":"10.1016\/j.vaccine.2015.08.043","article-title":"A systematic review of adverse events following immunization during pregnancy and the newborn period.","volume":"33","author":"T Fulton","year":"2015","journal-title":"Vaccine."},{"key":"ref-314","article-title":"WHO Meeting to develop Brighton Collaboration definitions of key terms used for monitoring the safety of immunization in pregnancy in mothers and newborn children.","year":"2014","journal-title":"Immunization, Vaccines and Biologicals."},{"key":"ref-315","article-title":"The GAIA consortium Wesite","year":"2016"},{"key":"ref-316","article-title":"Newsletter, September 2015","year":"2015"},{"key":"ref-317","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9627.1000108","article-title":"Pregnancy and Protection: The Ethics of Limiting a Pregnant Woman's Participation in Clinical Trials.","volume":"2","author":"L Allesee","year":"2011","journal-title":"J Clin Res Bioeth."},{"key":"ref-318","doi-asserted-by":"publisher","first-page":"632-633","DOI":"10.1016\/S0140-6736(10)60257-7","article-title":"Enrolling pregnant women in biomedical research.","volume":"375","author":"R Macklin","year":"2010","journal-title":"Lancet."},{"key":"ref-319","doi-asserted-by":"publisher","first-page":"6501-6502","DOI":"10.1016\/j.vaccine.2015.06.118","article-title":"Maternal immunization at the crossroads.","volume":"33","author":"C Pellegrini","year":"2015","journal-title":"Vaccine."},{"key":"ref-320","doi-asserted-by":"publisher","first-page":"6406-6412","DOI":"10.1016\/j.vaccine.2015.08.040","article-title":"Lessons learnt from enrolment and follow up of pregnant women and their infants in clinical trials in South Africa, a low-middle income country.","volume":"33","author":"C Cutland","year":"2015","journal-title":"Vaccine."},{"key":"ref-321","doi-asserted-by":"publisher","first-page":"6396-6400","DOI":"10.1016\/j.vaccine.2015.07.108","article-title":"Ethical considerations for designing GBS maternal vaccine efficacy trials in low-middle income countries.","volume":"33","author":"A White","year":"2015","journal-title":"Vaccine."},{"key":"ref-322","doi-asserted-by":"publisher","first-page":"6401-6405","DOI":"10.1016\/j.vaccine.2015.08.042","article-title":"Moving targets: The challenges of studying infectious diseases among pregnant women in resource limited settings.","volume":"33","author":"T Divala","year":"2015","journal-title":"Vaccine."},{"key":"ref-323","article-title":"International Ethical Guidelines for Biomedical Research Involving Human Subjects.","year":"2003"},{"key":"ref-324","article-title":"Clinical Development and Requirements for Licensure of Vaccines Intended for Use During Pregnancy to Prevent Disease in the Infant.","year":"2015"},{"key":"ref-325","doi-asserted-by":"publisher","first-page":"1887-1889","DOI":"10.1016\/S0140-6736(16)30394-4","article-title":"Mind the gap: jumping from vaccine licensure to routine use.","volume":"387","author":"K O'Brien","year":"2016","journal-title":"Lancet."},{"key":"ref-326","doi-asserted-by":"publisher","first-page":"2806-2809","DOI":"10.1016\/j.vaccine.2009.09.047","article-title":"Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles.","volume":"28","author":"B Lee","year":"2010","journal-title":"Vaccine."},{"key":"ref-327","doi-asserted-by":"publisher","first-page":"670-681","DOI":"10.1038\/nrmicro1472","article-title":"Bottlenecks and broomsticks: the molecular evolution of Mycobacterium bovis.","volume":"4","author":"N Smith","year":"2006","journal-title":"Nat Rev Microbiol."},{"key":"ref-328","doi-asserted-by":"publisher","first-page":"431-440","DOI":"10.1002\/sim.4780080407","article-title":"Surrogate endpoints in clinical trials: definition and operational criteria.","volume":"8","author":"R Prentice","year":"1989","journal-title":"Stat Med."},{"key":"ref-329","doi-asserted-by":"publisher","first-page":"2876-9","DOI":"10.1016\/j.vaccine.2015.12.072","article-title":"Status of vaccine research and development of vaccines for GBS.","volume":"34","author":"P Heath","year":"2016","journal-title":"Vaccine."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/5-2355\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/5-2355\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/5-2355\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T10:22:51Z","timestamp":1718792571000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/5-2355\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,22]]},"references-count":329,"URL":"https:\/\/doi.org\/10.12688\/f1000research.9363.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.10082.r16511","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.10082.r16507","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.10082.r16511","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.10082.r16507","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,22]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/5-2355\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.10082.r16511, Laura Elizabeth Riley, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, USA, 10 Oct 2016, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/5-2355\/v1#referee-response-16511","order":0,"name":"referee-response-16511","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.10082.r16507, Ronald Francis Lamont, Division of Surgery, Northwick Park Institute for Medical Research Campus, University College London, London, UK, 13 Oct 2016, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/5-2355\/v1#referee-response-16507","order":1,"name":"referee-response-16507","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"Part of this work was supported by a grant to WHO from the Bill & Melinda Gates Foundation: Global Health Grant OPP1134011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}